THE USE OF MEDOSTATIN AT DYSLIPIDEMIA TREATMENT IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH SUGAR DIABETES OF TYPE 2
https://doi.org/10.51523/2708-6011.2005-2-4-4
Abstract
Stating results of treatment of mediastinin dyslipidemia in patients of arterial hypertension with accompanying diabetes mellitus 2 type. Efficiansy and safety of medostatin in case of prolonged use are hoted.
References
1. Аметов А.С., Демидова Т.Ю., Косых С.А. Новые стратегии ангиопротективной терапии у больных сахарным диабетом 2 типа и артериальной гипертензией // Рос. кард. жур. - 2005. - № 1. - С. 47-54.
2. Kaplan M. Metabolic Aspects of Hypertension. Sciense press. - London, 1994.
3. Calles-Candon J et al. Coron. Art. Dis. - 1999. - № 10. - С. 23-30.
4. Kaplan N.M. New choices for the inicial drug therapy of hypertension // Am. J Cardiol. - 1988. - № 51. - Р. 1786-1788.
5. Laakso М. Diabetes Care Rev. - 1995.- № 3. - Р. 408-422.
6. Steiner G. Diabetes Care. - 1999. - Vol. 22. - № 3. - C. 6-9.
7. Ronnemaa T,.Laakso M.,Kallio V et al. // Am J Epidemiol. - 1989. - Vol. 130. - Р. 632-645.
8. Stamler J.,Vaccaro O., Neoton S.D.,Wentworth D. Diabetes Care. - 1993. - № 16. - Р. 434-444.
9. Turner R.C., Millns H., Neil H.A. et al. // Br. Меd. J. - 1998. - № 16. - Р. 823-828.
10. Fontbonnea A.,Escbwege E.,Cambien F.et al. // Diabetologia. - 1989. - № 6. - Р. 361-369.
11. Haffner S.M.,Alexander C.M.,Cook T.J.et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in Scandinavian Simvastatin Survival Study // Arch. Intern. Med. - 1999. - Vol. 159. - Р. 2661-2667.
Review
For citations:
Siluyanov V.V. THE USE OF MEDOSTATIN AT DYSLIPIDEMIA TREATMENT IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH SUGAR DIABETES OF TYPE 2. Health and Ecology Issues. 2005;(4):25-29. (In Russ.) https://doi.org/10.51523/2708-6011.2005-2-4-4
Views: 211
Email this article 